. 2018 May 18;9:451. doi: 10.3389/fphar.2018.00451

Table 1.

Mice examined in the present experiments.

Mouse number/total stimuli applied to achieve extended kindling	SRS events/monitoring times		AEDs tested in each mouse
	Initial^# (h)	Later^$ (h)
#1, 120	7/48	4/24	PHE^25mg/kg
#2, 140	13/72	16/144	PHE^25mg/kg
#3, 140	22/48	12/48	PHE^25mg/kg, LEV^100mg/kg
#4, 100	9/48	17/72	PHE^25mg/kg, LEV^100mg/kg
#5, 100	10/48	5/40	PHE^25mg/kg, LEV^100mg/kg
#6, 100	11/66	6/24	PHE^25mg/kg, LEV^100mg/kg
#7, 140	23/72	26/93	LOZ^1.5mg/kg, LEV^{100, 400mg/kg}
#8, 120	20/72	20/72	LOZ^1.5mg/kg, LEV^{100, 400mg/kg}
#9, 120	17/72	10/24	LOZ^1.5mg/kg, LEV^400mg
#10, 120	9/48	17/72	LOZ^1.5mg/kg, LEV^400mg
#11, 120	7/48	4/24	LOZ^1.5mg/kg, LEV^400mg
#12, 120	13/72	16/144	LOZ^1.5mg/kg, LEV^400mg
Mouse Number/totalandlings Applied
#1-#8, 120	0/48 h

PHE, phenytoin; LOZ, lorazepam; LEV, levetiracetam;

^{# and $}

individual mice were monitored initially within 3 days after termination of kindling stimulation; then, monitored 8–11 weeks later. Control mice were monitored after 120 handling manipulations.